CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,539
- in 2 filings, $289K under 10b5-1 plans
Net −$288,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −1,000 | $28.38 | $28K | 116,039.58 |
| 2024-06-13 | HASTINGS PAUL J Director | Sale 10b5-1 | −880 | $28.38 | $25K | 12,724 |
| 2024-06-13 | WILLIAMS KRISTEN Chief Administrative Officer | Sale 10b5-1 | −7,452 | $28.38 | $211K | 102,912 |
| 2024-06-12 | RIKER LAUREN Senior Vice President, Finance | Grant or award 10b5-1 | +21,360 | 42,045.34 | ||
| 2024-06-12 | RIKER LAUREN Senior Vice President, Finance | Sale 10b5-1 | −3,970 | $28.72 | $114K | 38,075.34 |
| 2024-06-12 | SLONIN JONATHAN Chief Medical Officer | Grant or award 10b5-1 | +54,300 | 98,869.48 | ||
| 2024-06-12 | CHRISTIE CHRISTOPHER Director | Grant or award | +5,230 | 10,491 | ||
| 2024-06-12 | CHRISTIE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +12,179 | 12,179 | ||
| 2024-06-12 | BIGAL MARCELO Director | Grant or award | +5,230 | 5,230 | ||
| 2024-06-12 | BIGAL MARCELO Director | Grant or award · Stock Option (Right to Buy) | +12,179 | 12,179 | ||
| 2024-06-12 | Reinhart Charles A. III Chief Financial Officer | Grant or award | +12,220 | 51,867 | ||
| 2024-06-12 | YANG MICHAEL J. Director | Grant or award | +5,230 | 5,230 | ||
| 2024-06-12 | YANG MICHAEL J. Director | Grant or award · Stock Option (Right to Buy) | +12,179 | 12,179 | ||
| 2024-06-12 | Ceesay Abraham Director | Grant or award | +5,230 | 5,230 | ||
| 2024-06-12 | Ceesay Abraham Director | Grant or award · Stock Option (Right to Buy) | +12,179 | 12,179 | ||
| 2024-06-12 | GAUGLER DARYL Chief Operating Officer | Grant or award 10b5-1 | +54,300 | 117,039.58 | ||
| 2024-06-12 | Froimson Mark Director | Grant or award | +5,230 | 13,073 | ||
| 2024-06-12 | Froimson Mark Director | Grant or award · Stock Option (Right to Buy) | +12,179 | 12,179 | ||
| 2024-06-12 | Young Alethia Director | Grant or award | +5,230 | 5,230 | ||
| 2024-06-12 | Young Alethia Director | Grant or award · Stock Option (Right to Buy) | +12,179 | 12,179 |
Page 7 of 9 · 161 trades